Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests

By James M. Robins, D. Finkelstein. Biometrics, 2000

848 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/dbd4f07f6d010459cb789150075b631d2384406c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Statistics and Probability

Citations in the corpus

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial. (2019, methodology): “One analysis used the inverse probability of censoring weighting method (IPCW), and the other used a two-stage survival analysis model.(17-20)”
Inference for the Complier-Average Causal Effect From Longitudinal Data Subject to Noncompliance and Missing Data, With Application to a Job Training Assessment for the Unemployed (2001, background): “Attempts have also been made to provide adjustments or bounds to the treatment effect in the presence of noncompliance (Balke and Pearl 1997; Baker 1998; Robins and Finkelstein 2000).”
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). (2015, background): “Statistical approaches to estimate longer-term clinical outcomes despite substantial treatment crossover have been developed [52, 53], and applied [54-57].”
Pattern–mixture and selection models for analysing longitudinal data with monotone missing patterns (2003, background): “E-mail: andrea@hsph.harvard.edu is censored at time t is independent of Y. Robins and Finkelstein (2000) called this assumption sequential ignorability.”
Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial. (2010, methodology): “Noncompliance is ignored here; it was previously described (17), and methods to account for noncompliance (18, 19) revealed only a modest difference from the hazard ratio obtained by intent-to-treat (20).”